Human Longevity Clinical Labs LLC Receives Accreditation from College of American Pathologists

News provided by

Apr 18, 2018, 03:11 ET

SAN DIEGO, April 18, 2018 /PRNewswire/ -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Human Longevity Clinical Labs LLC, San Diego, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.

The facility's director, Kenneth J. Bloom, MD was advised of this national recognition and congratulated for the excellence of the services being provided. Human Longevity Clinical Labs LLC is one of more than 8,000 CAP-accredited facilities worldwide.

HLI's CEO, J. Craig Venter, PhD said, "I am proud of our laboratory team for their hard work and diligence in achieving this important and necessary accreditation from CAP. We look forward to continuing to provide our clients with comprehensive and quality health information as part of our Health Nucleus experience."

The United States federal government recognized CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government's own inspection program.

During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety programs and record, and overall management.

About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, READ THE CAP ANNUAL REPORT at www.cap.org.

About Human Longevity, Inc.™
Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI's business focus includes the HLI Health Nucleus, a genomic-powered, clinical research and discovery center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health. For more information, please visit http://www.humanlongevity.com.

SOURCE Human Longevity, Inc.